Catalyst Brief

← Calendar

Readoutin 135d

Takeda — TDV

Phase 3 primary completion: A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years).

Date
Apr 2027
Type
Readout
Indication
Dengue Fever

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.